Contents

Search


mastodynia; mastalgia; breast pain

Also see breast lump/mass. Etiology: 1) premenstrual syndrome 2) fibrocystic breast disease 3) premature ovarian failure 4) causes associated with breast lump/mass 5) pharmaceutical agents - estradiol (Estrace, Estring, Estraderm, Estinyl, Climara, Delestrogen) - Premarin (conjugated estrogens) - estrogen-containing agents - oral contraceptives - hormone-replacement therapy (HRT) - estramustine - anastrozole (Arimidex) - bicalutamide (Casodex) - buserelin - cabergoline (Dostinex) - chlorpromazine (Thorazine, Ormazine) - perphenazine (Trilafon) - prochlorperazine (Compazine) - thioridazine (Mellaril) - thiothixene (Navane) - trifluoperazine (Stelazine, Suprazine) - aztreonam (Azactam) - carboprost or 15-methyl-prostaglandin F2-alpha (Hemabate) - fluphenazine (Prolixin) - leuprolide (Lupron) - medroxyprogesterone or acetoxymethylprogesterone (Provera, Cycrin, Amen) - megestrol (Megace) - methyltestosterone (Android, Testred, Metandren, Oretan, Virilon) - metoclopramide (Reglan) - minoxidil (Loniten, Rogaine) - norethindrone (Norlutate, Aygestin, Micronor) - norgestrel (Ovrette) Physical examination: - exclude palpable breast mass [2] Clinical manifestations: - cyclic mastalgia - most prominent during luteal phase of menstrual cycle - bilateral, throbbing discomfort Radiology: - annual screening mammogram should be recommended for women >= 40 years of age* [4] - reassurance without imaging should be offered to patients <= 40 years of age* [4] - breast ultrasound for non-cyclic breast pain [2] * excluding palpable breast mass Management: - most women with breast pain respond to reassurance & supportive measures: a) supportive, well-fitting bra (treatment of choice) [2] b) dietary measures 1] low-fat 2] methylxanthine restriction - no evidence that exclusion of methylxanthine from the diet improves symptoms [2] - pharmaceutical agents reserved for women with severe, persistent pain, not responding to supportive measures a) NSAIDs (topical diclofenac) first line for premenstrual breast pain [2] b) danazol (only FDA-approved agent for cyclic mastalgia) [2] c) tamoxifen d) bromocriptine [2]

General

sign/symptom

References

  1. Stedman's Medical Dictionary 26th ed, Williams & Wilkins, Baltimore, 1995
  2. Medical Knowledge Self Assessment Program (MKSAP) 15, 16, 17, 18. American College of Physicians, Philadelphia 2009, 2012, 2015, 2018. - Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025
  3. Miltenburg DM, Speights VO Jr. Benign breast disease. Obstet Gynecol Clin North Am. 2008 Jun;35(2):285-300, PMID: 18486842
  4. Kushwaha AC, Shin K, Kalambo M et al. Overutilization of health care resources for breast pain. AJR Am J Roentgenol 2018 Jul; 211:217 PMID: 29792736 https://www.ajronline.org/doi/10.2214/AJR.17.18879